Neurofibromatosis type 1 gene haploinsufficiency reduces AP-1 gene expression without abrogating the anabolic effect of parathyroid hormone

Calcified Tissue International

Volumn 78, Issue 3, 2006, Pages 162-170

  Yu, X ^a   Milas, J ^a   Watanabe, N ^a   Rao, N ^a   Murthy, S ^a   Potter, O L ^a   Wenning, M J ^a   Clapp, W D ^a   Hock, J M ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

c fos; Mouse; Neurofibromatosis type 1; Parathyroid hormone

Indexed keywords

ACTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG VEHICLE; GENE PRODUCT; MESSENGER RNA; NEUROFIBROMATOSIS 1 PROTEIN; NEUROFIBROMIN; PROTEIN; PROTEIN C FOS; PROTEIN JUN B; RECOMBINANT PARATHYROID HORMONE; RECOMBINANT PARATHYROID HORMONE[1-34]; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BONE MARROW CELL; BONE MASS; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; FEMUR; GENE EXPRESSION; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HORMONE RESPONSE; MALE; MOUSE; NEUROFIBROMATOSIS; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRESS FIBER; TREATMENT DURATION; WILD TYPE;

ACID PHOSPHATASE; ANIMALS; BONE DENSITY; BONE MARROW CELLS; CELLS, CULTURED; CYCLIC AMP; FEMUR; GENE EXPRESSION; GENES, NEUROFIBROMATOSIS 1; HUMANS; ISOENZYMES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARATHYROID HORMONE; RECOMBINANT PROTEINS; RIBONUCLEASES; RNA, MESSENGER; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTOR AP-1;

EID: 33645292604     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-005-0201-x     Document Type: Article

References (40)

1. Riccardi V, Womack JE, Jacks T (1994) Neurofibromatosis and related tumors. Natural occurrence and animal models. Am J Pathol 145:994-1000
2. Crawford A, Schorry E (1999) Neurofibromatosis in children: the role of the orthopedist. J Am Acad Orthop Surg 7:217-230
3. Vitale M, Guha A, Skaggs D (2002) Orthopedic manifestations of neurofibromatosis in children: an update. Clin Orthop Relat Res 1:107-118
4. Gilbert A, Brockman R (1995) Congenital pseudarthrosis of the tibia. Clin Orthop 314:37-44
5. Illes T, Halmai V, de Jonge T, Dubousset J (2001) Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12:823-827
6. Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J (2005) Decreased bone mineral density and content in neurofibromatosis type 1: lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928-936
7. Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM (2005) Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793-802
8. Elefteriou F, Benson DM, Liu X, Parada L, Karsenty G (2005) Neurofibromin (Nf1) through its expression in osteoblasts, controls bone formation and bone resorption. J Bone Miner Res (suppl 1):S14
9. McCormick F (1995) Ras signaling and NF1. Curr Opin Genet Dev 5:51-55
10. -/- cells. J Biol Chem 276:7240-7245
11. Zhu Y, Ghosh P, Charnay P, Burns D, Parada L (2002) Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296:920-922
12. Ingram DA, Yang FC, Travers JB, Wenning MJ, Hiatt K, New S, Hood A, Shannon K, Williams DA, Clapp DW (2000) Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 191:181-188
13. Lindsay R, Nieves J, Formica C, Henneman C, Woelfert L, Shen V, Dempster D, Cosman F (1997) Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 350: 550-555
14. Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17:2038-2047
15. Andreassen TT, Fledelius C, Ejersted C, Oxlund H (2001) Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand 72:304-307
16. Bollag G, Clapp D, Shih S, Adler F, Zhang Y, Thompson P, Lange B, Freedman M, McCormick F, Jacks T (1996) Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in hematopoietic cells. Nat Genet 12:144-148
17. Stanislaus D, Yang X, Liang J, Wolfe J, Cain R, Onyia J, Falla N, Marder P, Bidwell J, Queener S, Hock J (2000) In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone, hPTH 1-34 fragment. Bone 27:209-218
18. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P (1999) Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 14:1167-1174
19. Turner CH, Hsieh YF, Muller R, Bouxsein ML, Baylink DJ, Rosen CJ, Grynpas MD, Donahue LR, Beamer WG (2000) Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res 15:1126-1131
20. + T-lymphocytes in osteoclast differentiation in vitro. Endocrinology 137:2457-2463
21. Onyia J, Miller B, Hulman J, Liang J, Galvin R, Frolik C, Chandrasekhar S, Harvey A, Bidwell J, Herring J, Hock J (1997) Proliferating cells in the primary spongiosa express the osteoblast phenotype in vitro. Bone 20:93-100
22. Jerome C, Burr D, Bibber TV, Hock J, Brommage R (2001) Treatment with human parathryoid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150-159
23. Egan J, Gronowicz G, Rodan G (1991) Parathyroid hormone promotes the disassembly of cytoskeletal actin and myosin in cultured osteoblastic cells: mediation by cyclic AMP. J Cell Biochem 45:101-111
24. The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, Hariharan IK, Bernards A (1997) Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science 276:791-794
25. Gutmann D, Wu YL, Hedrick NM, Zhu Y, Guha A, Parada LF (2001) Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes. Hum Mol Genet 10:3009-3016
26. Ingram DA, Hiatt K, King AJ, Fisher L, Shivakumar R, Derstine C, Wenning MJ, Diaz B, Travers JB, Hood A, Marshall M, Williams DA, Clapp DW (2001) Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 194:57-69
27. Riccardi V (1992) Neurofibromatosis: phenotype, natural history and pathogenesis. Johns Hopkins University Press, Baltimore
28. Chen S, Ingram DA, Fisher L, Wenning MJ, Yu X, Hock JM, Clapp DW (2002) NF1 plays an essential role in osteoclasts development and its survival. Blood 100:81
29. Aubin JE, Alders E, Heersche JN (1983) A primary role for microfilaments, but not microtubules, in hormone-induced cytoplasmic retraction. Exp Cell Res 143:439-450
30. Chen C, Koh A, Zhang NDJ, Keller E, Xiao G, Franceschi R, D'Silva N, McCauley L (2004) Impact of the mitogen-activated protein kinase pathway on parathyroid hormone-related protein actions in osteoblasts. J Biol Chem 279:29121-29129
31. Fujita T, Meguro T, Fukuyama R, Nakamuta H, Koida M (2002) New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells. J Biol Chem 277:22191-22200
32. Miao D, Tong X, Chan G, Panda D, McPherson P, Goltzman D (2001) Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 276:32204-32212
33. Swarthout JT, Doggett TA, Lemker JL, Partridge NC (2001) Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J Biol Chem 276:7586-7592
34. Li J, Duncan RL, Burr DB, Gattone VH, Turner CH (2003) Parathyroid hormone enhances mechanically induced bone formation, possibly involving L-type voltage-sensitive calcium channels. Endocrinology 144:1226-1233
35. You J, Reilly GC, Zhen X, Yellowley CE, Chen Q, Donahue HJ, Jacobs CR (2001) Osteopontin gene regulation by oscillatory fluid flow via intracellular calcium mobilization and activation of mitogen-activated protein kinase in MC3T3-E1 osteoblasts. J Biol Chem 276:13365-13371
36. Fahsold R, Hoffmeyer S, Mischung C, Gille C, Ehlers C, Kucukceylan N, Abdel-Nour M, Gewies A, Peters H, Kaufmann D, Buske A, Tinschert S, Nurnberg P (2000) Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. Am J Hum Genet 66:790-818
37. Kano J, Sugimoto T, Kanatani M, Kuroki Y, Tsukamoto T, Fukase M, Chihara K (1994) Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation. J Cell Physiol 161:358-366
38. Nishida S, Tsubaki M, Hoshino M, Namimatsu A, Uji H, Yoshioka S, Tanimori Y, Yanae M, Iwaki M, Irimajiri K (2005) Nitrogen-containing bisphosphonate, YM529/ ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2. Biochem Biophys Res Commun 328:91-97
39. Theoleyre S, Wittrant Y, Couillaud S, Vusio P, Berreur M, Dunstan C, Blanchard F, Redini F, Heymann D (2004) Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. Biochim Biophys Acta 1644:1-7
40. Onyia J, Miles R, Yang X, Halladay D, HAle J, Glasebrook A, McClure D, Seno G, Churgey L, Chandrasekhar S, Martin T (2000) In vivo demonstration that parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J Bone Miner Res 16:863-871